The Pharmacy Times® Asthma resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
Digital health tools were a major theme during the first-ever NASP Challenge, comprising 4 of the 5 finalists.
The triple combination therapy is the first single inhaler triple therapy approved for both asthma and COPD and is the only single inhaler triple therapy available as a once-daily inhalation.
Contrary to earlier statements from the CDC, study suggests corticosteroid inhalers used by many asthmatics might make it more difficult for COVID-19 to enter the airways.
New research contradicts previous observational studies on the effect of vitamin D supplements in severe asthma prevention.
Week in Review: Researchers Investigate Whether Asthma Increases Risk of Contracting, Severity of COVID-19
Top news of the week from Pharmacy Times®.
As a chronic respiratory disease, asthma has been considered a risk factor for COVID-19 by many experts and clinicians.
The inhaler sends data back to a mobile app in real time.
Contrary to World Health Organization recommendations, the benefits of steroids used in inhalers and nebulizers outweigh the risks.
The dupilumab pen features a hidden needle and single-press auto-injection, along with visual and audio feedback to help with administration.
Generic products featured in the May 2020 issue.
Patients with COVID-19 between the ages of 20 and 59 years who also had asthma needed a ventilator to assist with breathing for 5 days more on average than non-asthmatic patients with COVID-19, according to a press release.
The National Institutes of Health (NIH) has issued a timely statement emphasizing the importance of asthma awareness and standing with parents, families, advocates, researchers, and health care professionals.